Subbu Nambi
Stock Analyst at Guggenheim
(3.59)
# 827
Out of 4,967 analysts
43
Total ratings
57.14%
Success rate
5.9%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Maintains: Buy | $32 → $36 | $36.56 | -1.53% | 2 | Aug 13, 2025 | |
| DHR Danaher | Reiterates: Buy | $250 | $203.79 | +22.68% | 2 | Jul 23, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $88 → $115 | $128.18 | -10.28% | 1 | Jun 30, 2025 | |
| TEM Tempus AI | Maintains: Buy | $65 → $75 | $78.34 | -4.26% | 3 | Jun 30, 2025 | |
| NEOG Neogen | Maintains: Buy | $13 → $10 | $5.64 | +77.30% | 3 | Jun 30, 2025 | |
| ILMN Illumina | Maintains: Buy | $122 → $114 | $97.82 | +16.54% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $26.24 | +90.55% | 2 | May 6, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $10 | $8.83 | +13.31% | 1 | Apr 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $60 | $48.01 | +24.97% | 2 | Apr 11, 2025 | |
| MYGN Myriad Genetics | Downgrades: Neutral | n/a | $6.90 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $37 | $30.11 | +22.88% | 3 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $33.23 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $56 | $66.51 | -15.80% | 5 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $169.34 | +18.11% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $31.61 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.37 | +78.04% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.67 | +792.59% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.37 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $120.69 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $24.21 | +3.26% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.28 | - | 1 | Dec 14, 2023 |
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $36.56
Upside: -1.53%
Danaher
Jul 23, 2025
Reiterates: Buy
Price Target: $250
Current: $203.79
Upside: +22.68%
GeneDx Holdings
Jun 30, 2025
Maintains: Buy
Price Target: $88 → $115
Current: $128.18
Upside: -10.28%
Tempus AI
Jun 30, 2025
Maintains: Buy
Price Target: $65 → $75
Current: $78.34
Upside: -4.26%
Neogen
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $5.64
Upside: +77.30%
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $97.82
Upside: +16.54%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $26.24
Upside: +90.55%
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $8.83
Upside: +13.31%
Exact Sciences
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $48.01
Upside: +24.97%
Myriad Genetics
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $6.90
Upside: -
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $30.11
Upside: +22.88%
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $33.23
Upside: -
Feb 24, 2025
Reiterates: Buy
Price Target: $56
Current: $66.51
Upside: -15.80%
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $169.34
Upside: +18.11%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $31.61
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.37
Upside: +78.04%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.67
Upside: +792.59%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.37
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $120.69
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $24.21
Upside: +3.26%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.28
Upside: -